Celebrating our 10th anniversary – Unlock our special offer today

Premium reports US federal: CBD and cannabis regulation
0

US federal: CBD and cannabis regulation

Published: 30th August 2023 | No. pages: 16
$1,995.00

Description

Pressure has mounted on the federal government to regulate CBD products in the years since the 2018 Farm Bill passed. However, there has been a stalemate between Congress and the Food and Drug Administration (FDA), with each side pointing the finger at each other to act and leaving little hope for a break-through in the near future.

Despite most states legalising cannabis for medical and/or recreational use and wide popular support for legalisation, the federal government is only likely to make modest reforms to cannabis policy in the near future.

This report provides detailed analysis around the current regulatory framework in place on a federal level in the US for hemp, CBD, other cannabinoids as well as medical and recreational cannabis.

Reasons to buy

This CannIntelligence regulatory report will provide you with:

  • A clear and detailed understanding of current regulatory requirements affecting this sector in a specific jurisdiction, enabling you to be confident your business and your products are compliant.
  • The ability to plan ahead for specific regulatory changes.
  • Strategic understanding of the policy climate within the jurisdiction, enabling you to forecast how it might affect business development.
  • Sources of further information, for example, links to full texts of legislation and contact details for relevant government offices.

Table of contents

  1. Executive summary
  2. Outlook
  3. Introduction
  4. Hemp and CBD
  5. Medical cannabis
  6. Recreational cannabis
  7. Relevant laws
  8. Relevant bodies

Methodology

Our research is completely independent and original. It is conducted by CannIntelligence’s multilingual legal analysis team, all specialists in this sector, and goes through a rigorous review and editing process before publication. Research draws on multiple sources, including: online and offline resources and data, specialist legal software, our own extensive databases and report archives, interviews with key stakeholders and government officials, and collaboration with local legal firms and on-the-ground professionals in the jurisdictions covered.

Latest reports

Description

Pressure has mounted on the federal government to regulate CBD products in the years since the 2018 Farm Bill passed. However, there has been a stalemate between Congress and the Food and Drug Administration (FDA), with each side pointing the finger at each other to act and leaving little hope for a break-through in the near future.

Despite most states legalising cannabis for medical and/or recreational use and wide popular support for legalisation, the federal government is only likely to make modest reforms to cannabis policy in the near future.

This report provides detailed analysis around the current regulatory framework in place on a federal level in the US for hemp, CBD, other cannabinoids as well as medical and recreational cannabis.

Get a free sample of this premium report:

“ US federal: CBD and cannabis regulation ”

    -

    “ US federal: CBD and cannabis regulation ”